Compare DFTX & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DFTX | XMTR |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.8B |
| IPO Year | 2020 | 2021 |
| Metric | DFTX | XMTR |
|---|---|---|
| Price | $30.21 | $121.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 12 |
| Target Price | $72.83 | ★ $125.55 |
| AVG Volume (30 Days) | ★ 1.5M | 812.3K |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.95 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $686,631,000.00 |
| Revenue This Year | N/A | $37.31 |
| Revenue Next Year | N/A | $22.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.87 |
| 52 Week Low | $14.62 | $35.86 |
| 52 Week High | $49.70 | $127.49 |
| Indicator | DFTX | XMTR |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 65.13 |
| Support Level | $20.43 | $83.30 |
| Resistance Level | $38.59 | N/A |
| Average True Range (ATR) | 2.10 | 9.34 |
| MACD | -0.21 | 1.91 |
| Stochastic Oscillator | 3.34 | 86.19 |
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.